Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GLB1 | P16278 | 1/20 | 0.33 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL271586 | 1.00 | ALDH1A1 (0.65) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL3312607 | 0.90 | ALDH1A1 (0.59) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL28525044 | 0.90 | ALDH1A1 (0.59) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL27933386 | 0.84 | ALDH1A1 (0.52) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| Azobenzene SCHEMBL27886536 | 0.81 | ALDH1A1 (0.70) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL7639 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL473081 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL15748432 | 0.80 | ALDH1A1 (0.61) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL19851313 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL13823021 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024246941-A1 | A COMBINATION OF SUCCINATE CONSUMING MICROBIOTAS | TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (IN) | 2024-12-05 | — | — | WO | claimed |
| US-11980877-B1 | 4,4′-divinylazobenzene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 moieties as an inorganic catalyst | King Faisal University (SA) | 2024-05-14 | — | — | US | claimed |
| US-11981691-B1 | 1,4-divinylphenylene-bridged diruthenium complex bearing two Ru(CO)(2-mercaptoquinolato)(PIPR3)2 moieties as an organic catalyst | King Faisal University (SA) | 2024-05-14 | — | — | US | claimed |
| US-11945828-B1 | Electronically weakly coupled 4,4′-divinylazobenzene-bridged diruthenium complex bearing two Ru(CO)Cl (PiPr3)2 moieties as an inorganic catalyst | King Faisal University (SA) | 2024-04-02 | — | — | US | claimed |
| US-9890351-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-13 | — | — | US | claimed |
| EP-2741731-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-17 | — | — | EP | claimed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | claimed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | claimed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | claimed |
| US-4663308-A | Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract | MEDICAL COLLEGE OF OHIO (US) | 1987-05-05 | — | — | US | claimed |
| WO-2024246941-A1 | A COMBINATION OF SUCCINATE CONSUMING MICROBIOTAS | TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE (IN) | 2024-12-05 | — | — | WO | disclosed |
| US-11987596-B1 | Polyelectrochromism of electronically weakly coupled 4,4′-divinylazoarylene-bridged two Ru(CO)Cl(PiPr3)2 entities | King Faisal University (SA) | 2024-05-21 | — | — | US | disclosed |
| US-11986809-B1 | 4,4-divinylazoarylene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 as an inorganic catalyst | King Faisal University (SA) | 2024-05-21 | — | — | US | disclosed |
| US-11980877-B1 | 4,4′-divinylazobenzene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 moieties as an inorganic catalyst | King Faisal University (SA) | 2024-05-14 | — | — | US | disclosed |
| US-11980877-B1 | 4,4′-divinylazobenzene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 moieties as an inorganic catalyst | King Faisal University (SA) | 2024-05-14 | — | — | US | disclosed |
| US-5407682-A | Process for the preparation of azo-and /or disulfide polymer matrix drug delivery system for the site specific delivery of an active agent in the colon | DANBIOSYST UK LTD AISHA (GB) | 1995-04-18 | — | — | US | disclosed |
| EP-0513035-B1 | PROCESS FOR THE PREPARATION OF AZO- AND/OR DISULFIDE-CONTAINING POLYMERS | DANBIOSYST UK (GB) | 1993-10-20 | — | — | EP | disclosed |
| US-5032572-A | Drug delivery | MEDICAL COLLEGE OF OHIO (US) | 1991-07-16 | — | — | US | disclosed |
| US-4826954-A | Diorganopolysiloxane-azobenzene alternating copolymers and methods for their preparation | TORAY SILICONE CO., LTD. (JP) | 1989-05-02 | — | — | US | disclosed |
| US-4663308-A | Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract | MEDICAL COLLEGE OF OHIO (US) | 1987-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | ALDH1A1 696/4885TSHR 4882/4885MEN1 1592/4885 |
| US-11986809-B1 | 4,4-divinylazoarylene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 as an inorganic catalyst | PIP4K2A, PIP4K2B, PIP4K2C | ALDH1A1 2844/4885TSHR 3696/4885MEN1 4093/4885 |
| US-11980877-B1 | 4,4′-divinylazobenzene-bridged diruthenium complex bearing Ru(CO)Cl(PiPr3)2 moieties as an inorganic catalyst | PIP4K2B, PIP4K2C, PI4K2B | ALDH1A1 3753/4885TSHR 3793/4885MEN1 4077/4885 |
| US-11945828-B1 | Electronically weakly coupled 4,4′-divinylazobenzene-bridged diruthenium complex bearing two Ru(CO)Cl (PiPr3)2 moieties as an inorganic catalyst | PIP4K2B, PIP4K2C, PIP4K2A | ALDH1A1 3755/4885TSHR 3840/4885MEN1 4091/4885 |
| US-11981691-B1 | 1,4-divinylphenylene-bridged diruthenium complex bearing two Ru(CO)(2-mercaptoquinolato)(PIPR3)2 moieties as an organic catalyst | PIP4K2A, PIP4K2B, PIP5K1A | ALDH1A1 2526/4885TSHR 4092/4885MEN1 3452/4885 |
| US-11987596-B1 | Polyelectrochromism of electronically weakly coupled 4,4′-divinylazoarylene-bridged two Ru(CO)Cl(PiPr3)2 entities | BICRA, LIG3, PIP4K2A | ALDH1A1 4143/4885TSHR 3192/4885MEN1 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.